Which patients for bisphosphonate control of breast cancer metastasis?

ST GALLEN, SWITZERLAND—Bisphosphonates have an important part to play in managing breast cancer according to research reported at the 2013 St Gallen conference on “Primary Therapy of Early Breast Cancer”. Professor Robert Coleman, from Weston Park Hospital and the University of Sheffield in the UK told Peter Goodwin about findings from the AZURE study and from other research indicating that controlling bone turnover by using bisphosphonates can modulate the metastatic process favourably in post-menopausal women, but should not be used in younger women.

LISTEN

[audio:https://www.audiomedica.com/podcasting/oncology/130323RobertColemanPODCASTLoRes.mp3]